financetom
Business
financetom
/
Business
/
Pilgrims Pride Insider Sold Shares Worth $2,892,344, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Pilgrims Pride Insider Sold Shares Worth $2,892,344, According to a Recent SEC Filing
Aug 6, 2024 2:45 PM

05:27 PM EDT, 08/06/2024 (MT Newswires) -- Fabio Sandri, President and CEO, on August 06, 2024, sold 65,000 shares in Pilgrims Pride ( PPC ) for $2,892,344. Following the Form 4 filing with the SEC, Sandri has control over a total of 279,565 shares of the company, with 279,565 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/802481/000080248124000077/xslF345X03/wk-form4_1722979332.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Australia's ANZ sells 16.5% interest in Malaysia's AmBank
Australia's ANZ sells 16.5% interest in Malaysia's AmBank
Mar 5, 2024
(Reuters) - Australia's fourth-biggest bank ANZ Group ( ANZGF ) said on Wednesday it has agreed to sell a 16.5% stake in Malaysian lender AMMB Holdings for 3.85 ringgit ($0.8134) apiece through a block trade. The deal has been upsized to a 16.5% stake sale from 9% previously agreed on March 5, according to a term sheet seen by Reuters....
Cricut Q4 Earnings Flat, Revenue Declines
Cricut Q4 Earnings Flat, Revenue Declines
Mar 5, 2024
04:19 PM EST, 03/05/2024 (MT Newswires) -- Cricut ( CRCT ) reported Q4 earnings late Tuesday of $0.05 per diluted share, flat from a year earlier. One analyst polled by Capital IQ expected a break-even. Revenue for the quarter ended Dec. 31 was $231.25 million, down from $280.76 million a year earlier. Two analysts polled by Capital IQ expected $252.67...
Apellis Pharmaceuticals Insider Sold Shares Worth $16,028,706, According to a Recent SEC Filing
Apellis Pharmaceuticals Insider Sold Shares Worth $16,028,706, According to a Recent SEC Filing
Mar 5, 2024
04:18 PM EST, 03/05/2024 (MT Newswires) -- Cedric Francois, Director, Chief Executive Officer, on March 01, 2024, sold 250,000 shares in Apellis Pharmaceuticals ( APLS ) for $16,028,706. Following the Form 4 filing with the SEC, Francois has control over a total of 2,035,230 shares of the company, with 313,662 shares held directly and 1,721,568 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1492422/000112760224008505/xslF345X03/form4.xml...
EU set to allow possible retroactive tariffs for Chinese EVs
EU set to allow possible retroactive tariffs for Chinese EVs
Mar 5, 2024
BRUSSELS, March 5 (Reuters) - The European Commission plans to start customs registration of Chinese electric vehicle (EV) imports, meaning they could be hit by tariffs from that point if the EU's trade investigation later concludes that they are receiving unfair subsidies. The Commission is carrying out an anti-subsidy investigation into Chinese battery EVs to determine whether to impose tariffs...
Copyright 2023-2026 - www.financetom.com All Rights Reserved